CMTAWinter2021Report

…discovered that he too had CMT. Kaya and her family’s greatest hope is that treatments are found to prevent/stop progression of CMT and that a cure will soon be within…

2020_CMTA_PFC_Fireside_Chat_transcript

…is there’s also an amazing dedicated board of directors, who probably want a treatment and a cure more than we do. They wanted it for us. They wanted it for…

Winter_2020_CMTA_Report

treatments, as they will allow researchers to know whether certain treatments are feasible before launching a full study. The event raised more than $235,000 for STAR research, much of it…

2019_What_Is_CMT

…on CMT. Is there a Treatment for CMT? Although there is no drug treatment for CMT, physical/occupational therapy and moderate activity (but not overexertion) can help maintain muscle strength, endurance…

2019_What_Is_CMT

…on CMT. Is there a Treatment for CMT? Although there is no drug treatment for CMT, physical/occupational therapy and moderate activity (but not overexertion) can help maintain muscle strength, endurance…

What_Is_CMT_4-2017

…testing. Please visit www.cmtausa.org/diagnosis for more information. What are the Symptoms of CMT? Is there a Treatment for CMT? Although there is no drug treatment for CMT, physical therapy and…

What_Is_CMT_4-2017

…testing. Please visit www.cmtausa.org/diagnosis for more information. What are the Symptoms of CMT? Is there a Treatment for CMT? Although there is no drug treatment for CMT, physical therapy and…

2017_Winter_CMTA_Report

…the reader may use to aid and supplement a doctor’s treatment. CMTA LEADERSHIP CMTA STAFF Gilles Bouchard, Interim CEO BOARD OF DIRECTORS Gilles Bouchard, Chairman Gary Gasper, Treasurer Herb Beron,…

2015_Boston_PFC_Agenda

…clinician, electromyographer, and educator whose work is focused on the evaluation, diagnosis, care and treatment of patients with neuromuscular disorders, including ALS, peripheral neuropathy, myasthenia gravis, myopathies and muscular dystrophies….

CMTAreportSpring2022

…further the development of gene therapy treatments for CMT. Conklin, Judge and their team aim to develop and validate a therapeutic gene editing platform for dominant CMT2E mutations using human…